S
troke is a leading cause of death and long-term disability in the United States. 1 An estimated 795 000 Americans experience a new or recurrent stroke, resulting in >135 000 deaths and >829 000 hospital admissions per year. 2 Direct and indirect costs for stroke in 2008 are estimated at >$65 billion in the United States. 3 Because of the large proportion of stroke survivors with long-term disability, the true cost due to diminished productivity and reduced quality of life among disabled survivors of stroke and their caregivers is likely even greater. Therefore, identifying modifiable risk factors for stroke is of significant public health interest.
A large body of literature shows that short-term increases (ie, over hours to days) in ambient particulate matter (PM) are associated with higher risk of cardiovascular morbidity and mortality [4] [5] [6] [7] [8] [9] [10] and triggering of myocardial infarction, 11, 12 arrhythmias, [13] [14] [15] and heart failure exacerbations. [16] [17] [18] The effects of short-term exposure are thought to be mediated through a combination of autonomic, hemostatic, inflammatory, and vascular endothelial disturbances with consequent changes in cardiac and vascular function. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Given the putative pathophysiologic mechanisms thought to underlie these effects, it is plausible that transient elevations in PM could similarly increase the risk of stroke. Specifically, acute PM-related changes in blood pressure, vascular function, atherosclerotic plaque stability, and hemostatic balance could increase the risk of atherothrombotic strokes; acute elevations in blood pressure or vascular endothelial activation could trigger small vessel (lacunar) strokes; episodes of atrial fibrillation could lead to increased risk of cardioembolic stroke; and transient elevations in arterial blood pressure could increase the risk of cerebral hemorrhage. 31 However, relatively fewer studies have evaluated this hypothesis and the results have been inconsistent, with some, [32] [33] [34] [35] but not other, [36] [37] [38] [39] [40] studies finding evidence of a positive association. The evidence linking short-term changes in ambient PM to the risk of stroke morbidity or mortality has not been systematically reviewed. Accordingly, our aim is to provide a comprehensive review and meta-analysis of the association between short-term changes in ambient PM levels and risk of stroke morbidity and mortality.
Methods Search Strategy and Data Abstraction
We searched PubMed, Web of Knowledge, and Embase databases to identify all observational human studies, published in English from January 1966 to January 2014, evaluating the relationship between short-term changes in ambient PM levels and hospital admissions, emergency department visits, or deaths for stroke or cerebrovascular disease, using the terms "particulate matter" or "particle" in combination with "stroke" or "cerebrovascular disease." We also retrieved additional studies from the references of these articles to identify studies not captured by the initial search.
The initial study selection was based on the examination of the titles and/or abstracts among all the identified articles. The full texts of all potentially relevant articles were further reviewed. Studies were included in the meta-analysis if they examined the association of fine PM (PM 2.5 , PM with aerodynamic diameter <2.5 lm), respirable PM (PM 10 , PM with aerodynamic diameter <10 lm), or coarse PM (PM 2.5-10 , PM with aerodynamic diameter between 10 and 2.5 lm) 0 to 4 days before the event with total cerebrovascular disease, ischemic stroke, transient ischemic attack, or hemorrhagic stroke. We excluded from review any studies that did not report point estimates or 95% CIs, and those where the outcome reflected a composite end point of stroke and other diseases (eg, International Classification of Diseases, Ninth Revision [ICD-9]: 430 to 448 or diagnosis related group [DRG] 14 to 17, 22) .
Two reviewers independently abstracted data from each article, including study population (geographic location, age, sex), study design, outcome definition, outcome assessment (death certificate, administrative data, medical records), PM size fractions and average exposure levels, available lags considered, and measures of association. For each study we abstracted results for all outcomes, PM size fractions, and/or lagged exposures reported. All discrepancies regarding study eligibility or details were resolved by consensus between the reviewers.
Statistical Analyses
We separately evaluated the evidence for or against an association between each PM size fraction (PM 2.5 , PM 10 , PM 2.5-10 ), each outcome (total cerebrovascular disease, ischemic stroke/transient ischemic attack, hemorrhagic stroke), and separately for mortality and hospital admission, yielding a total of 39392=18 potential separate analyses. For each analysis, we used a DerSimonian and Laird randomeffects model to estimate the summary percent change in relative risk of the outcome per 10-lg/m 3 increase in PM.
When results from both single-and multi-pollutant models were available, we included only results from single-pollutant We assessed publication bias by performing Egger regression test for funnel asymmetry in addition to visual inspection of the funnel plots. If there was evidence of publication bias, we additionally applied trim and fill methods to adjust for publication bias. 44 We assessed the heterogeneity across studies by computing a P value based on the Cochran's Q statistic, although this statistic has low power when the sample size is small. We also calculated the I 2 statistic, the percentage of variation across studies explained by heterogeneity rather than chance. Unlike the Q statistics, the I 2 statistics is not inherently dependent on sample size and is more intuitive.
Sensitivity Analyses
We performed sensitivity analyses pooling effect estimates of the same lag group reported in individual studies or by geographic locations (Europe, East Asia, Latin America, North America, and Australia). We also performed sensitivity analyses excluding studies that defined cerebrovascular disease using a subset of ICD codes (eg, ICD-10: 60 to 61, 63 to 64), as opposed to the broader definition of ICD-10: 60 to 69 in other studies for the same category or excluding studies using administrative records in case ascertainment, as opposed to medical review performed in stroke registry. All analyses were performed using "metafor" package in R statistical software (R v2.13). A 2-sided P value of <0.05 was considered statistically significant.
Results
In our initial literature search, we identified 480 human observational studies potentially eligible for inclusion. After reviewing the titles, abstracts, and full texts, there were 60 studies that were potentially eligible for review and metaanalysis ( Figure 1 ). We excluded 15 of these studies because they did not report point estimates or confidence Thus, this review and meta-analysis consisted of 45 studies reporting point estimates and 95% CIs for the association between short-term exposures to PM 2.5 , PM 10 , or PM 2.5-10 and Studies were conducted in Europe (n=20), East Asia (n=12), North America (n=11), Australia (n=1), and Latin America (n=1), using either time-series (n=29) or casecrossover (n=16) study designs. Mean PM levels reported in the studies varied widely for PM 2.5 (range 5.0 to 31.6 lg/m 3 ), PM 10 (6.9 to 187.1 lg/m 3 ), and PM 2.5-10 (7.5 to 14.6 lg/ m 3 ). In mortality studies, mortality was ascertained based on death certificates from local, regional, and national public health agencies. Hospital admission events were ascertained based on administrative/billing data, emergency department logs, or review of medical records or from existing stroke registries. The lag periods considered included single-day lags (lag 0, 1, 2, 3, 4) and cumulative lags up to 4 days (ie, 1-to 4-day moving average) before the event.
PM 2.5 and Hospital Admission
Total cerebrovascular disease A random-effects summary estimate of the association between PM 2.5 and hospital admission for total cerebrovascular disease suggests a nonsignificant 0.3% (95% CI À0.5% to 1.2%) higher risk of hospitalization for total cerebrovascular disease per 10-lg/m 3 increase in PM 2.5 ( Figure 2 ). These studies were significantly heterogeneous (I 2 =64.16%, P=0.04). The largest study was Dominici et al, 33 which evaluated this association among 11.5 million Medicare beneficiaries aged ≥65 years residing in 204 US urban Figure 4 . A, Funnel plot of individual study relative risk (95% CI) for the association between particulate matter PM 2.5 and hospital admissions for cerebrovascular disease (CBVD); (B) after applying trim and fill methods to adjust for publication bias.
counties. The authors found a statistically significant 0.8% (95% CI 0.3% to 1.3%) higher risk of hospital admission for total cerebrovascular disease per 10-lg/m 3 increase in PM 2.5 . An additional 8 studies evaluated this association in diverse populations, with 4 reporting a positive association and 4 reporting a negative association between PM 2.5 and risk of hospitalization for total cerebrovascular disease ( Figure 3 ). We found that the association between PM 2.5 and hospital admission for total cerebrovascular disease varied by geographic locations, with East Asia and North America showing statistically significant positive associations (Table 3) . Sensitivity analyses pooling point estimates by individual lag subgroups (lag 0, lag 1, lag 2, lag 3 and lag 0 to lag 1) did not materially change the results (Table 3) . The results did not materially change when excluding studies that defined hospital admissions using ICD-10: 60 to 61, 63 to 64 39 as opposed to ICD-10: 60 to 69 as used in all other studies (Table 3) . We observed evidence suggestive of publication bias (Egger regression test, P=0.02; Figure 4A ). When we applied trim and fill methods (estimated 4 studies missing) to adjust for publication bias, such evidence disappeared (Egger regression test, P=0.95; Figure 4B ), but these studies remained heterogeneous (I 2 =79.55%, P=0.001).
Ischemic stroke
We reviewed 6 studies evaluating the association between PM 2.5 and risk of ischemic stroke hospitalization. Figure 5 ). A random-effects summary estimate suggests a nonsignificant 1.3% (95% CI À4.2% to 7.0%) higher risk of ischemic stroke hospitalization per 10-lg/m 3 increase in PM 2.5 ( Figure 2 ).
These studies were significantly heterogeneous (I 2 =64.41%, P=0.03), and there was no evidence of publication bias (Egger regression test, P=0.39; Figure 6 ). Results were qualitatively similar in sensitivity analyses by individual lag subgroups or when excluding studies using administrative records in case ascertainment ( Table 3 ). The associations did not vary by geographic locations (Table 3) .
Hemorrhagic stroke
We found only 2 studies that evaluated the association between PM 2.5 and the risk of hospitalization for hemorrhagic stroke, 32,37 both of which reported no evidence of an association ( Figure 7 ). The random-effects summary estimate suggests a nonsignificant À1.0% (95% CI À4.5% to 2.6%) lower risk of hospitalization for hemorrhagic stroke per 10-lg/m 3 increase in PM 2.5 ( Figure 2 ). There was no evidence of heterogeneity across studies (I 2 =0, P=0.93), and the Egger regression test statistic for funnel plot symmetry could not be computed due to the small sample size (Figure 8 ). Sensitivity analyses by individual lag subgroups or geographic locations did not materially change the results (Table 3) .
PM 2.5 and Mortality
We reviewed 5 studies 41, [70] [71] [72] 77 examining the association between PM 2.5 and cerebrovascular mortality, all of which reported a positive association ( Figure 9 ). The random-effects summary estimate suggests a statistically significant 1.4% (95% CI 0.9% to 1.9%) higher risk of cerebrovascular mortality per 10-lg/m 3 increase in PM 2.5 ( Figure 2 ). These studies were homogeneous (I 2 =6.78%, P=0.28), and we found no evidence suggestive of publication bias (Egger regression test P=0.43; Figure 10 ). Results did not materially change in sensitivity analyses pooling point estimates by individual lag subgroups or excluding 2 studies that defined total cerebro- used in other studies ( Table 3 ). The associations did not vary by geographic locations (Table 3) .
PM 10 and Hospital Admission
Total cerebrovascular disease
We reviewed 12 studies 8, 32, 36, [45] [46] [47] [48] [49] [50] [51] [52] [53] of the association between PM 10 and hospitalization for the composite end point of all cerebrovascular disease ( Figure 11 Figure 2 ). These studies were heterogeneous (I 2 =76.54%, P=0.001) with no evidence of publication bias (Egger regression test, P=0.94; Figure 12 ). The results did not materially change in sensitivity analyses pooling effect estimates by individual lag subgroups or when excluding hospital admission cases defined by ICD-10: 61 to 64 8 ( Table 3 ). The associations were largely insensitive to stratification by geographic locations with the exception of Latin America, where we observed a greater increase in risk compared with other locations (Table 3) .
Ischemic stroke
We reviewed 8 studies 32, 37, 42, 57, 58, [61] [62] [63] evaluating the association between PM 10 and risk of hospitalization for ischemic stroke ( Figure 13 ). In Taiwan, Tsai et al found a positive, statistically significant association but only on days with a mean temperature ≥20°C. Wellenius et al found a statistically for the association between particulate matter PM 2.5 and mortality for cerebrovascular disease (CBVD).
significant, positive association between PM 10 and ischemic stroke hospitalization among Medicare beneficiaries aged ≥65 years residing in 6 US cities. The remaining studies failed to find evidence of a statistically significant, positive association between PM 10 and ischemic stroke hospitalization. Using data from a Danish national stroke registry, Andersen et al found positive, but not statistically significant, associations, with a somewhat stronger and sometimes statistically significant association among patients presenting without comorbid atrial fibrillation. Henrotin et al also found a positive, but not statistically significant, association between PM 10 levels and ischemic stroke hospitalization in the context of the Dijon Stroke Registry. The random-effects summary estimate is null (0.0% [95% CI À2.4% to 2.4%]) and currently does not support the presence of an overall association between PM 10 and ischemic stroke hospitalization (Figure 2 ). These studies were heterogeneous (I 2 =86.53%, P<0.0001), and sensitivity analyses pooling estimates by individual lag subgroups did not materially change the results (Table 3) . The results were largely insensitive to stratification by geographic locations with the exception of East Asia, where we observed a greater increase in relative risk compared with other locations (Table 3 ).There is evidence suggestive of publication bias (Egger regression test, P=0.03; Figure 14A ). When we applied trim and fill methods to adjust for publication bias (estimated 4 missing studies), we no longer observed evidence of publication bias (Egger regression test, P=0.85; Figure 14B ), but these studies remained heterogeneous (I 2 =86.74%, P<0.0001).
Hemorrhagic stroke
Most, 32, 37, 42, 58, 63 but not all, 42 studies failed to find any association between short-term exposure to PM 10 and Figure 11 . Individual study relative risk (95% CI) for the association between particulate matter PM 10 and hospital admissions for cerebrovascular disease (CBVD). for the association between particulate matter PM 10 and hospital admissions for cerebrovascular disease (CBVD).
hospital admission for hemorrhagic stroke ( Figure 15 ). The notable exception was the study by Tsai et al in Taiwan, which found a positive and statistically significant association but only on days with a mean temperature ≥20°C. The randomeffects summary estimate suggests a 0.9% (95% CI À2.4% to 4.3%) higher risk of hemorrhagic stroke hospital admission per 10-lg/m 3 in PM 10 ( Figure 2 ). The pooled studies exhibited considerable heterogeneity (I 2 =78.84%, P=0.0001).
Sensitivity analyses by individual lag subgroups or geographic locations did not materially change the results (Table 3) . We did not observe publication bias (Egger regression test, P=0.22; Figure 16 ). reported a positive and statistically significant association between PM 10 and cerebrovascular mortality only in the warm season (May to October). The random-effects summary of 0.5% (95% CI 0.3% to 0.7%) higher risk of cerebrovascular mortality per 10-lg/m 3 increase in PM 10 supports the presence of a statistically significant association between PM 10 and cerebrovascular mortality (Figure 2 ). These studies were heterogeneous (I 2 =84.25%, P<0.0001), and there is evidence suggestive of publication bias (Egger regression test, P=0.05; Figure 18A ). When we applied trim and fill methods to adjust for publication bias (estimated 3 missing studies), we no longer observed publication bias (Egger regression test, P=0.99; Figure 18B ), but these studies remained heterogeneous (I 2 =40.72%, P=0.01). The results did not materially change in sensitivity analyses pooling point estimates by individual lag subgroups or excluding 2 studies that defined total cerebrovascular mortality using ICD-10: 60 to 61, 63 to 64 41 or ICD-10: 61, 63, and 69
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( Table 3 ). The associations did not vary by geographic locations (Table 3) .
PM 2.5-10 and Hospital Admission
We found 4 studies 36, 39, 50, 52 that examined the association between PM 2.5-10 and hospital admission for cerebrovascular diseases, and the results were heterogeneous (Figure 19) . Two of these studies 36, 52 reported a positive, but not statistically significant, association, while the other 2 studies 39,50 reported a negative but not statistically significant association. We did not include the study by Peng et al, because they did not report the association between PM 2.5-10 and cerebrovascular hospital admission. The random-effects summary of À0.9% (95% CI À5.4% to 3.8%) excess relative risk suggests that short-term exposure to PM 2.5-10 is not associated with hospital admissions for total Table 3 ).
PM 2.5-10 and Mortality
Three 70, 73, 75 studies reported effect estimates for the association between short-term exposure to PM 2.5-10 and total cerebrovascular disease mortality ( Figure 21 ). In 47 US cities, Zanobetti and Schwartz 2009 found a 0.8% (95% CI 0.1% to 1.6%) higher risk of total cerebrovascular disease mortality per 10-lg/m 3 increase in PM 2.5-10 over 2 days before deaths.
The summary estimate of 0.7% (95% CI À0.5% to 1.9%) excess relative risk does not yet support the presence of a statistically significant association between PM 2.5-10 and cerebrovascular mortality (Figure 2 ). These studies were not heterogeneous (I 2 =46.83%, P=0.12), and we did not observe publication bias (Egger regression test, P=0.21; Figure 22 ). Sensitivity analysis limited to the European studies yielded a summary estimate of 1.1% (95% CI À2.2% to 4.5%) higher risk of total cerebrovascular disease per 10-lg/m 3 increase in PM 2.5-10 . 
Discussion
Findings of key epidemiologic studies and the meta-analyses presented here suggest that particulate matter air pollution is associated with a statistically significant higher risk of cerebrovascular disease mortality, with weaker evidence for the presence of associations with different types of strokes such as ischemic and hemorrhagic strokes. Specifically, we found a summary estimate of 1.4% (95% CI 0.9% to 1.9%) higher risk of cerebrovascular mortality per 10-lg/m 3 increase in PM 2.5 . Several studies suggest that hospital admission for total cerebrovascular disease or ischemic stroke may be associated with PM 2.5 , but the weight of the published evidence does not yet show a positive and statistically significant association, as suggested by the summary estimates of 0.3% (95% CI À0.5% to 1.2%) and 1.3% (95% CI À4.2% to 7.0%) excess relative risk, respectively. Only 2 studies have specifically considered hemorrhagic stroke, but these studies do not suggest that risk of hemorrhagic stroke is associated with PM 2.5 levels. Results for PM 10 were similar to those for PM 2.5 . Specifically, we found a summary estimate of 0.5% (95% CI 0.3% to 0.7%) higher risk of cerebrovascular mortality per 10-lg/m 3 increase in PM 10 . The evidence for the presence of an association between PM 10 and hospital admission for total cerebrovascular disease or ischemic stroke remains inconsistent, as suggested by the summary estimates of 0.3% (95% CI À0.1% to 0.8%) and 0.0% (95% CI À2.4% to 2.4%) excess risk per 10-lg/m 3 increase in PM 10 , respectively. Additional large studies will be needed to convincingly demonstrate the presence or absence of these associations in future meta- analyses. The few available studies do not clearly suggest an association between PM 10 and hospital admissions for hemorrhagic stroke. Substantially fewer studies have considered the association between PM 2.5-10 and cerebrovascular mortality or morbidity and the evidence currently available does not indicate the presence of such associations, as suggested by summary estimates of 0.9% (95% CI 5.4% to 3.8%) and 0.7% (95% CI À0.5% to 1.9%) excess risk per 10-lg/m 3 increase in PM 2.5-10 , respectively. We found no studies relating PM 2.5-10 specifically with risk of ischemic stroke or hemorrhagic stroke hospitalization. The meta-analytic summary estimates often masked considerable variability among studies, even where we did not find statistically significant heterogeneity. There are likely multiple sources that may explain this underlying variability in results across studies. First, ambient particulate matter is a heterogeneous mixture of various compounds (eg, organic and elemental carbon, metals, sulfates, nitrates, and microorganisms) from multiple sources (eg, traffic, manufacturing, power generation). The role of each component or source-individually or in conjunction-as an acute trigger of cardiovascular events including stroke remains unclear. 78 Second, exposure misclassification may bias effect estimate toward the null 79 and may arise from different strategies used to assess PM exposure at the community level and the type of air pollution monitoring network accessible to researchers. For example, O'Donnell et al estimated city-specific associations between ischemic stroke hospital admission and PM 2.5 using measurements from 19 monitors in cities of various sizes in Ontario, Canada. They found a À0.7% (95% CI À6.3% to 5.1%) decrease in hospital admission for ischemic stroke when including monitoring data from all cities. After only including cases with monitoring data from the 4 largest cities, where >1 single monitor in each city was used, they found a 1.1% (95% CI À4.0% to 6.5%) higher risk of hospital admission for ischemic for the association between particulate matter PM 2.5-10 and mortality for cerebrovascular disease (CBVD).
stroke, perhaps due to reduction of exposure misclassification. In addition, delay times from stroke onset to hospital presentation can lead to exposure misclassification, which may bias the results toward the null. 79 Third, cerebrovascular disease and stroke are composite end points that include strokes of different etiologies (eg, ischemic versus intracerebral hemorrhage versus subarachnoid hemorrhage). It seems plausible that PM would have different associations with risk of acute ischemic stroke versus intracerebral hemorrhage. Even ischemic stroke is a heterogeneous disease with multiple potential etiologies including large artery atherothombosis, small vessel disease, cardioembolic events, and other less common ischemic stroke etiologies. Indeed, there is limited evidence to suggest that some etiologic subtypes of ischemic stroke may be more strongly associated with PM. 59 As the distribution of ischemic stroke etiologies varies across populations, even specifically considering studies of ischemic stroke leaves considerable room for heterogeneity in outcome. Fourth, studies using ICD-9/10 codes to ascertain ischemic or hemorrhagic stroke often lead to outcome misclassification and is expected to have biased effect estimates toward the null hypothesis of no association. 80 Stroke registries in which cases are ascertained by medical record review can be valuable source for identifying cases particularly for studying stroke of different etiologies. Fifth, current epidemiologic studies often account for temporal or meteorologic confounders in different ways. Finally, differences in demographic characteristics of underlying population (eg, percent of participants younger than 65 years old), local meteorology, average PM levels, or quality control of ascertainment of stroke and subtypes (eg, interindividual variations between medical coders during stroke ascertainment) may also contribute to heterogeneity of results across studies including the observed geographic variations of the association between PM 2.5 and hospital admission for total cerebrovascular disease. For example, the elderly and those with certain comorbid conditions are thought to be more susceptible to cardiovascular effects of air pollution. 78 To the extent that population demographics and the distribution of stroke risk factors and comorbid conditions vary greatly across study populations, this may contribute substantially to the heterogeneity of results across studies.
Research Gaps and Recommendations
These results highlight a number of important gaps in the current literature. First, most prior studies have evaluated a composite end point of cerebrovascular events, but additional large studies specifically considering ischemic stroke, ischemic stroke subtypes, and hemorrhagic stroke are still needed.
Second, few studies to date have evaluated whether the association between PM and stroke varies by PM composition or source. Studies to identify PM components or sources most relevant to stroke mortality and morbidity are needed. Third, most studies have focused on PM 2.5 and PM 10 but study of PM 2.5-10 is also warranted for its relevance to morbidity, as evidenced in prior studies of association with cardiovascular disease. 56 We did not have sufficiently large sample size to draw a conclusion for PM 2.5-10 in this study. Fourth, given the heavy reliance of prior studies on administrative data, outcome misclassification due to the use of ICD codes is prevalent in current studies particularly for stroke subtypes. More epidemiologic studies based on registry data or using medical record review for outcome ascertainment should be carried out to replicate current results. Additionally, history of prior stroke is an important risk factor for stroke, but few studies have considered recurrent versus first stroke. 55 Studies are needed to evaluate the association between stroke recurrence and particulate matter. Fifth, few studies have identified subgroups of the population that may be at increased risk of stroke mortality and morbidity. In addition, studies are needed to identify whether or not patients with non-cardioembolic (largeartery atherosclerosis, small-vessel disease) or cardioembolic ischemic stroke are at greater risk of hospital admission for ischemic stroke associated with PM 10 . Sixth, most available studies of ischemic stroke and subtypes or hemorrhagic stroke suffer from exposure misclassification due to the use of date of hospital admission rather than date and time of stroke symptom onset. Novel epidemiologic study design or statistical methods of data analysis that address this issue may help minimize such misclassification. Seventh, given the inconsistent results for an association between PM 10 and hospital admission for total cerebrovascular diseases, additional large studies are needed to replicate the current results for PM 10 . Eighth, given a borderline significant increase in risk of hospital admission for ischemic stroke associated with PM 2.5 within 24 hours but not 48 hours of onset, more studies are need to evaluate the temporal window of PM 2.5 exposure most relevant to ischemic stroke and subtypes. To conclude, more studies, particularly large studies that simultaneously leverage statistical correction of exposure or outcome errors, case ascertainment via physician diagnosis and accurate exposure data for PM components or PM 2.5-10 are warranted to further elucidate the association between short-term change in ambient particulates and stroke.
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